It was reported that blood leakage was occurred on gas outlet of oxygenator during treatment.Customer did not change the product since leakage was occurred just before the withdrawal of extracorporeal circulation.Operation was completed without any problem and patient was not affected.No harm to any person has been reported.The sample was investigated at getinge laboratory.Visual control was performed and there could not found external damage on the product.Leak test was performed for 6 hours and there was not any leakage occurred on blood side.Tightness test was also performed for water side and gas side and there could not be found any abnormalities.No abnormalities were found during the flow test.According to the test results, the reported failure could not be reproduced during laboratory investigation, technical cause of the failure could not be determined.Based on the test results, failure could not be confirmed.The production records of the affected oxygenator were reviewed on 2022-08-25.Following tests are performed according to the bop as a 100 % inspection: ¿ leak test after welding ; ¿ pressure test heat exchanger; ¿ leak test water side ; ¿ leak and flow test gas side ; ¿ pressure test blood side ; ¿ coating test.According to the final test results, the oxygenator with the serial# 1773269 passed the test as per specifications.Production related influences can be excluded.The production history records (dhrs) of the affected bo-vkmo 51000 with lot# 3000164569 was reviewed on 2022-06-10.According to the dhr result, the product bo-vkmo 51000 passed the defined manufacturing and final release specifications.There is no indication on manufacturing issues.Thus production related influences are unlikely.The failure could be linked to the risk assessment file of quadrox-i small adult/adult, quadrox-id adult and probable cause could be: -lack of information - vapor permeation while normothermic water within the water compartment is interacting with un-heated medical gas / oxygen within gas exchange compartment user identifies condensation as "leakage".The occurrence rate was calculated for the reported failure and product and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|